Highlighting the Human Cost of Commercial Payor Latency
By Dr. Sandeep Palakodeti, MD, MPH
In the evolving landscape of healthcare, evidence-based interventions are the gold standard for patient care. However, the system is fraught with inefficiencies and disparities, often leaving patients without access to treatments that could significantly improve their quality of life. One such glaring example is the Intracept Procedure, a revolutionary treatment for chronic low back pain. Despite its proven efficacy and coverage by Medicare, the procedure remains inaccessible for many due to the lack of coverage by commercial payors. This phenomenon, as we are dubbing it the "Commercial Payor Latency," serves as a poignant example of the systemic issues plaguing our healthcare system. Let’s take a deeper dive into this issue, using the Intracept Procedure as a case study to highlight the human cost of such systemic failures.
The Intracept Procedure
The Intracept Procedure is a minimally invasive treatment that targets the basivertebral nerve for the relief of chronic vertebrogenic low back pain. Unlike traditional surgical interventions, the Intracept Procedure does not alter the spinal structure, thereby reducing the risk of complications. The procedure has been the subject of multiple clinical trials, including the Intracept study, which demonstrated a significant reduction in pain and improvement in function for patients undergoing the procedure. | The procedure involves the insertion of a specialized probe into the vertebral body to ablate the basivertebral nerve. This nerve is often a significant contributor to chronic low back pain, and its ablation has been shown to provide long-lasting relief. The entire procedure takes approximately 60 minutes and is performed under conscious sedation, allowing patients to return to their normal activities within a few days. | As network partner, Dr. Tim Canty, eloquently states, “The Intracept Procedure has emerged as a game-changer showing remarkable results in abating chronic vertebrogenic low back pain. In other words - pain from a degenerative disc in the low back. Normally patients with this problem have been told they need a large surgery to fuse the spine. Instead the Intracept procedure can be performed nonsurgically with minimal recovery time, making it an ideal choice for many of my patients. Medicare has recognized its efficacy and safety profile, yet commercial insurance carriers lag behind, often citing outdated or less relevant data, keeping patients from relief. It's high time for payers to align their coverage policies with the latest evidence-based practices to enhance patient outcomes and reduce the overall burden on the healthcare system.”
Direct Care: A Model for Transparency and Access
In a healthcare landscape often marred by opaque pricing structures and restricted access, direct care stands as a beacon of transparency and equity. Direct Care Organizations like Mishe are pioneering this approach, offering patients seamless access to medical care without the bureaucratic red tape that often accompanies insurance-based models. In a direct pay system, patients pay for services directly, bypassing the need for insurance pre-approvals and the associated delays. | This model is particularly relevant for procedures like Intracept, which are evidence-based but not yet widely covered by commercial payors. In a direct pay environment, the patient and healthcare provider can make decisions based on medical necessity rather than insurance limitations. Procedures like the Intracept intervention are offered at discounted prices and patients exchange directly with physicians. There are no prior auths other than the physician consult and medical clearance. This not only expedites access to care but also places the focus squarely on patient outcomes.
Problem: Commercial Payor Latency
The term "Commercial Payor Latency" refers to the delay or outright refusal by commercial insurance companies to cover evidence-based medical procedures. This latency is not merely an administrative issue; it reflects a systemic problem that has far-reaching implications. In the case of the Intracept Procedure, despite its proven efficacy and Medicare coverage, commercial payors have yet to include it in their list of covered treatments. | This latency often stems from a variety of factors, including bureaucratic inertia, cost considerations, and sometimes, a lack of awareness about the latest medical advancements. The end result is a healthcare system that is slow to adapt, leaving patients and healthcare providers in a state of limbo. Especially confusing and complicated for patients and clinicians alike: the discrepancy between the Commercial and Medicare coverage - Medicare has clearly seen the evidence and deemed this a covered benefit, so why haven’t Commercial insurers caught up?
The Human Cost
The impact of Commercial Payor Latency is not just financial; it has a profound human cost. For patients suffering from chronic low back pain, every day without effective treatment is a day lost to suffering, reduced productivity, and diminished quality of life. The mental toll of living with chronic pain can lead to depression, anxiety, and other mental health issues, creating a vicious cycle that is hard to break. | Moreover, the lack of insurance coverage forces many to forego the Intracept Procedure, opting instead for less effective treatments or, worse, addictive pain medications. This not only exacerbates the opioid crisis but also places an additional burden on healthcare resources, as untreated or inadequately treated patients are more likely to seek emergency care.
A Call to Action
We must challenge the status quo and push for a healthcare system that is more responsive to evidence-based treatments. The direct pay environment, as exemplified by Mishe.co, offers a glimpse into what is possible when we prioritize patient care over bureaucracy. | Commercial Payor Latency is not just a term; it's a barrier that prevents people from receiving the care they need. By highlighting the case of the Intracept Procedure, we hope to provoke thought and inspire change. Let's work together to create a healthcare system that truly serves its purpose: to heal.